中药干预对22例2型糖尿病颈动脉内中膜厚度动态变化的影响
本文选题:颈动脉内中膜厚度 + 2型糖尿病 ; 参考:《北京中医药大学》2016年硕士论文
【摘要】:本研究论文主要分为两部分:综述和临床研究。综述又分为现代医学综述和中医学综述。现代医学综述部分主要介绍了糖尿病大血管病变流行病学情况、发病的主要机制、诊断方法、相关的实验室指标、目前治疗研究的进展及可能的不良反应作用做了相关整理。提示糖尿病大血管病变发病机制复杂,相关研究主要从多元醇通路、晚期糖化终产物、胰岛素抵抗、血脂异常、炎症等多方面阐释,其治疗主要以降糖、控压、调脂等对因处理,其疗效评价有待进一步完善和综合考量。中医学综述部分,笔者检索了近15年来关于糖尿病大血管病变的中医诊治的部分相关研究,简要概述了中医对糖尿病大血管病变病因病机、临床分型、辨证论治的研究进展,并对不同类型的大血管病变分别进行了梳理,同时对相关中药的最新研究也进行了学习,初步认为中医和中西医结合对糖尿病大血管并发症的治疗有一定的特色和优势。临床研究目的探讨中药干预对2型糖尿病颈动脉内中膜厚度动态变化的影响。方法采用回顾性研究,以2010年1月至2015年12月在北京医院内分泌科及中医科住院病人为研究对象,根据纳入、排除标准,筛选出以西医规范的降糖、降压、调脂治疗为基础且数据资料完整的42份病历,分为两组:中药干预组22例,暴露于中药干预,于住院及门诊口服中药,中药剂量及种类由接诊医生通过中医辨证开具;对照组20例,未暴露于中药干预,即单纯西医常规治疗。42份病历于2010年1月至2015年12月住院3次,2次住院间隔时间1-1.5年。观察主要指标:3次住院期间颈动脉内中膜厚度,比较两组之间动态变化情况的差异;次要指标:空腹静脉血糖,血清总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、糖化血红蛋白、血清尿酸、血清尿素氮,血清肌酐等。结果两组颈动脉内中膜厚度整体较前变薄,中药干预组内中膜厚度变薄幅度较西医常规治疗组的大,但无统计学差异(P=0.083);合并心脑血管病变患者内中膜厚度(1.7±0.6(mm))和不合并心脑管病变患者内中膜厚度(1.4±0.2(m))有明显统计学差异(P0.05);两组患者在第2次住院时,次要观察指标肌酐(SCr)中药干预组64±16(mmol/L)低于西医常规治疗组75±15(mmol/L),且结果有统计学差异(P0.05)。患者第三次住院时中药干预组糖化血红蛋白(7.7±1.03(%))较对照组(8.54±1.53(%))低,但结果无统计学意义(P=0.058);患者第二次入院时对照组FIB-C(2.85±0.50g/L)比中药干预组(3.47±0.83g/L)低,有显著统计学差异(P=0.006)。结论中药干预联合西药常规治疗对2型糖尿病颈动脉内中膜厚度的改善程度可能优于单纯西药常规治疗;颈动脉内中膜厚度和心脑血管并发症相关;中药干预可能对该组病患的肾功能有保护作用;中药干预联合西药常规治疗可能能够更有效的降低患者HbA1c水平。
[Abstract]:This research paper is divided into two parts: summary and clinical research. The review is divided into modern medicine review and traditional Chinese medicine review. The part of modern medicine review mainly introduces the epidemiology of diabetic macroangiopathy, the main pathogenesis, diagnostic methods, related laboratory indexes, the progress of current treatment research and possible adverse reactions. It is suggested that the pathogenesis of diabetic macroangiopathy is complicated, and the related studies mainly include polyol pathway, advanced glycosylation end products, insulin resistance, dyslipidemia, inflammation and so on. The evaluation of the therapeutic effect of lipid adjustment and other factors needs further improvement and comprehensive consideration. In the part of summary of traditional Chinese medicine, the author searched some related studies on the diagnosis and treatment of diabetic macrovascular disease in the past 15 years, and briefly summarized the research progress of TCM in the etiology, pathogenesis, clinical classification, syndrome differentiation and treatment of diabetic macrovascular disease. Different types of macrovascular diseases were combed, and the latest research on traditional Chinese medicine was also studied. It was preliminarily concluded that the treatment of diabetic macrovascular complications by TCM and Western medicine has certain characteristics and advantages. Objective to investigate the effect of traditional Chinese medicine (TCM) intervention on the dynamic changes of carotid artery thickness in type 2 diabetes mellitus. Methods from January 2010 to December 2015, the inpatients in the Department of Endocrinology and the Department of traditional Chinese Medicine of Beijing Hospital were studied by retrospective study. According to the inclusion and exclusion criteria, the standard of lowering blood sugar and blood pressure in western medicine was selected. 42 cases with complete data were divided into two groups: Chinese medicine intervention group (22 cases) exposed to Chinese medicine intervention, oral Chinese medicine in inpatient and outpatient department, and the dosage and type of traditional Chinese medicine were prescribed by TCM syndrome differentiation. In the control group, 20 cases were not exposed to the intervention of traditional Chinese medicine, that is, 42 cases of routine western medicine were hospitalized 3 times from January 2010 to December 2015. The interval between hospitalization and hospitalization was 1-1.5 years. Main outcome measures: carotid intima-media thickness was observed during three hospitalizations, and the difference of dynamic changes between the two groups was compared. Secondary measures: fasting venous blood glucose, serum total cholesterol, triglyceride, low density lipoprotein cholesterol, High density lipoprotein cholesterol, glycosylated hemoglobin, serum uric acid, serum urea nitrogen, serum creatinine, etc. Results the intima media thickness of carotid artery in both groups was thinner than that in the former group, and the thickness of internal media in the Chinese medicine intervention group was larger than that in the routine western medicine treatment group. However, there was no statistical difference between the two groups (P < 0.083; medial thickness was 1.7 卤0.6mm in patients with cardiovascular and cerebrovascular diseases) and that in patients without cardio-cerebral canal disease was 1.4 卤0.2mm); there was a significant difference between the two groups in the second hospitalization, and there was no significant difference between the two groups (P < 0.05). The index of creatinine in the intervention group (64 卤16 mmol/ L) was lower than that in the conventional western medicine group (75 卤15 mmol / L), and the difference was statistically significant (P 0.05). The glycosylated hemoglobin in the intervention group (7.7 卤1.03g / L) was lower than that in the control group (8.54 卤1.53g / L), but the results were not statistically significant, and the FIB-C(2.85 卤0.50g / L in the control group on the second admission was lower than that in the Chinese medicine intervention group (3.47 卤0.83g / L), there was significant difference between the two groups (P 0.006). Conclusion the degree of improvement of carotid intima-media thickness in type 2 diabetes mellitus may be better than that of traditional Chinese medicine intervention combined with routine treatment of western medicine, which is related to cardiovascular and cerebrovascular complications. The intervention of traditional Chinese medicine may protect the renal function of the patients, and the intervention of traditional Chinese medicine combined with routine therapy of western medicine may reduce the level of HbA1c more effectively.
【学位授予单位】:北京中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 陈一奇,贺大桥,陈国生,荣大庆,柳佰富;肠内早期中药干预治疗多器官功能不全综合征[J];中国中西医结合外科杂志;2000年04期
2 李红山;冯琴;朱德东;李德周;傅琪琳;;瘦素在非酒精性脂肪性肝炎患者中的动态变化及中药干预作用[J];中华中医药学刊;2013年09期
3 陈乔;吕进;朱金华;侯吉华;;影响记忆的因素及中药干预研究概述[J];时珍国医国药;2014年04期
4 景光婵;张孟仁;;脑源性神经生长因子对血糖影响机制及中药干预研究[J];医学研究杂志;2010年08期
5 余肖;范钦华;;中药干预对防治增生性玻璃体视网膜病变的基础研究[J];四川中医;2013年11期
6 杨蕴,黄万琪,周威;大学生心理障碍的中药干预研究[J];健康心理学杂志;2004年03期
7 张志远;苗明三;;中药干预无症状HIV感染者的研究思路探讨[J];山西中医学院学报;2008年03期
8 陈南官;廖颖文;周智文;陈家前;;中药干预治疗慢性肺源性心脏病急性发作期临床观察[J];中国中医急症;2009年09期
9 路娟;胡继宏;;体外中药干预骨髓间充质干细胞向心肌细胞分化的研究进展[J];中国医药科学;2014年04期
10 刘艳民,李杰,李庆和,韩娟;情志应激与Ⅱ型糖尿病的基因表达及中药干预的实验研究[J];天津中医;2001年05期
相关会议论文 前10条
1 赵久龄;王玉水;袁静;王欣;;中药干预治疗儿童幽门螺杆菌感染的临床研究[A];第28次全国中医儿科学术大会暨2011年名老中医治疗(儿科)疑难病临床经验高级专修班论文汇编[C];2011年
2 崔骥;许家佗;邸智;屠立平;崔龙涛;陈清光;于波;;大学生亚健康状态中药干预前后脉图分析[A];第四届全国中医药博士生优秀论文专辑[C];2013年
3 王德惠;杜瑞斌;周祺;;中药干预葡萄糖耐量低减的疗效观察[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
4 祝娉婷;李湘鸣;卜平;;中药干预Ⅱ相酶防肿瘤作用及机理研究[A];江苏省抗癌协会传统医学与抗癌药物专业委员会年会论文汇编[C];2006年
5 张红;韩克;谈勇;;中药干预妇科恶性肿瘤患者化疗间期和康复期生存质量的研究[A];中华医学会第九次全国妇科肿瘤学术会议论文汇编[C];2006年
6 林谦;农一兵;段文慧;;早期中药干预对急性心肌梗死远期预后影响的回顾性研究[A];第六次全国中西医结合血瘀证及活血化瘀研究学术大会论文汇编[C];2005年
7 宁光;;中药干预胰岛素抵抗的研究进展[A];2008内分泌代谢性疾病系列研讨会暨中青年英文论坛论文汇编[C];2008年
8 阿娜尔汗;居来提;姑再努尔;;亚临床甲状腺功能减低合并冠心病的中药干预治疗[A];第三届全国中西医结合心血管病中青年论坛暨新疆中西医结合学会心血管专业委员会第二届学术研讨会论文汇编[C];2013年
9 陈可冀;史大卓;徐浩;刘剑刚;;动脉粥样硬化防治技术平台及中药干预作用的系统研究[A];全国中西医结合发展战略研讨会暨中国中西医结合学会成立三十周年纪念会论文汇编[C];2011年
10 刘清池;张慧敏;李建英;马亚辉;马传宝;庞宇慧;梁春耕;吴维海;冯新旺;武大勇;;骨髓增生异常综合征患者生命质量调查与中药干预[A];2011年浙江省中医药学会血液病分会学术年会暨国家中医临床研究基地血液病研究2011高峰论坛暨国家级继续教育中西医结合血液病新进展学习班文集[C];2011年
相关重要报纸文章 前1条
1 于伟邋李水根;灾区伤员疗疾重视传统疗法[N];健康报;2008年
相关博士学位论文 前1条
1 张兰凤;冠心病合并抑郁症证候特征与中药干预临床研究[D];中国中医科学院;2011年
相关硕士学位论文 前10条
1 成晓强;中药干预对22例2型糖尿病颈动脉内中膜厚度动态变化的影响[D];北京中医药大学;2016年
2 张继娟;慢性咳嗽的中医体质评价及中药干预前后探讨[D];广州中医药大学;2010年
3 冯悦;大黄对冠心病炎症反应干预作用的临床研究[D];山东大学;2011年
4 石冬霞;中药干预对中老年人亚临床甲状腺功能减退预后影响的临床研究[D];湖北中医药大学;2013年
5 朱W,
本文编号:1939907
本文链接:https://www.wllwen.com/zhongyixuelunwen/1939907.html